(PharmaNewsWire.Com, April 20, 2017 ) As per the syndicated report published by Market Data Forecast Europe Regenerative Medicines Market which is estimated to be USD 5.06 billion in 2016 is poised to reach USD 13.56 billion by 2021, at a CAGR of 21.80% from 2016 to 2021. It can be attributed to the factors such as growing aging population, rising advancements and governments involvement in R&D, increasing number of lifestyle disorders like obesity, diabetes etc. as well as the increasing population suffering from chronic diseases.However certain challenges like stringent government laws and uncertain regulatory guidelines, must be dealt with to attain the full potential.
Regenerative medicines are used to replace,repair or regenerate human cells, tissues, or any organ affected due to disease, injury, congenital defects, aging processes, and damage due to trauma. These medicines help restoring normal functions of cells and tissues. These medicines are available in different forms such as genes, stem cells,somatic cells, and other types. Some of them (such as stem cells) have the ability to differentiate,proliferate thereby restoring the original structure of either tissues or cells or organs.
Regenerative medicines are generally used for varied range of degenerative disorders including cardiovascular, dermatology, neuro degenerative diseases, and orthopaedic, among others. Majority of the scientists focus on the development of advanced technologies to provide better quality of regenerative medicines and efficient healthcare treatment solutions for patients.
Europe Regenerative Medicines Market is segmented based on product, therapy and applicationas mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based onProduct: Cell-BasedProducts Autologous Cell-Based Products Allogeneic Cell-Based Products Acellular Products Based on Therapy: Cell Therapy Gene Therapy Tissue Engineering Immunotherapy Based on Application: Orthopedic & Musculoskeletal Spine Dermatology Cardiovascular Central Nervous System Oncology Diabetes Other Applications
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe). As per the study France is poised to hold the major market share while Germany is the fastest growing market in this region.
Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd., Cytori Therapeutics Inc., Advantagene, Inc., and Mesoblast Ltd. are the major players operating in the Europe Regenerative Medicines Market. According to recent reports, Acelity L.P. made an announcement about selling its regenerative medicine companyLifeCell Corp. to Allergan for USD 2.9 billion. The Regenerative Medicines market study offers the following deliverables: Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providingmarket size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors thataffect the European market presented in the form ofPESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
